Evaluating the Performance of the Astral Mass Analyzer for Quantitative Proteomics Using Data-Independent Acquisition.
data-independent acquisition
high-resolution mass spectrometry
plasma
quantitative proteomics
Journal
Journal of proteome research
ISSN: 1535-3907
Titre abrégé: J Proteome Res
Pays: United States
ID NLM: 101128775
Informations de publication
Date de publication:
06 10 2023
06 10 2023
Historique:
medline:
9
10
2023
pubmed:
8
9
2023
entrez:
8
9
2023
Statut:
ppublish
Résumé
We evaluate the quantitative performance of the newly released Asymmetric Track Lossless (Astral) analyzer. Using data-independent acquisition, the Thermo Scientific Orbitrap Astral mass spectrometer quantifies 5 times more peptides per unit time than state-of-the-art Thermo Scientific Orbitrap mass spectrometers, which have long been the gold standard for high-resolution quantitative proteomics. Our results demonstrate that the Orbitrap Astral mass spectrometer can produce high-quality quantitative measurements across a wide dynamic range. We also use a newly developed extracellular vesicle enrichment protocol to reach new depths of coverage in the plasma proteome, quantifying over 5000 plasma proteins in a 60 min gradient with the Orbitrap Astral mass spectrometer.
Identifiants
pubmed: 37683181
doi: 10.1021/acs.jproteome.3c00357
pmc: PMC10563156
mid: NIHMS1932032
doi:
Substances chimiques
Peptides
0
Proteome
0
Blood Proteins
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
3290-3300Subventions
Organisme : NIA NIH HHS
ID : P30 AG013280
Pays : United States
Organisme : NIGMS NIH HHS
ID : R24 GM141156
Pays : United States
Organisme : NIA NIH HHS
ID : U19 AG065156
Pays : United States
Commentaires et corrections
Type : UpdateOf
Références
Mol Cell Proteomics. 2002 Nov;1(11):845-67
pubmed: 12488461
Nat Methods. 2022 Jul;19(7):774-779
pubmed: 35534633
J Proteome Res. 2022 Jul 1;21(7):1718-1735
pubmed: 35605973
Curr Opin Chem Biol. 2021 Feb;60:1-9
pubmed: 32599342
Anal Chem. 2009 Aug 1;81(15):6481-8
pubmed: 19572557
Bioinformatics. 2010 Apr 1;26(7):966-8
pubmed: 20147306
Nat Methods. 2023 Mar;20(3):339-346
pubmed: 36899164
Mol Cell Proteomics. 2023 Feb;22(2):100489
pubmed: 36566012
Nat Biotechnol. 2012 Oct;30(10):918-20
pubmed: 23051804
Cell Syst. 2017 Jun 28;4(6):587-599.e4
pubmed: 28601559
Proteomics. 2013 Mar;13(5):723-6
pubmed: 23307342
J Proteome Res. 2021 Sep 3;20(9):4435-4442
pubmed: 34319745
Mol Cell Proteomics. 2020 Jul;19(7):1088-1103
pubmed: 32312845
Anal Chem. 2023 Aug 15;95(32):11854-11858
pubmed: 37527417
Mol Syst Biol. 2022 Mar;18(3):e10798
pubmed: 35226415
Nat Methods. 2020 Dec;17(12):1229-1236
pubmed: 33257825
Mol Cell Proteomics. 2019 May;18(5):1027-1035
pubmed: 30833379
Clin Chem. 2014 Jul;60(7):941-4
pubmed: 24812416
Theranostics. 2022 Jan 31;12(5):1988-1998
pubmed: 35265194
Mol Cell Proteomics. 2022 Sep;21(9):100279
pubmed: 35944843
Sci Data. 2014 Sep 16;1:140031
pubmed: 25977788
Nat Methods. 2019 Jun;16(6):509-518
pubmed: 31133760
Anal Chem. 2021 Dec 21;93(50):16751-16758
pubmed: 34881875
Nat Commun. 2021 Jun 7;12(1):3341
pubmed: 34099695
J Proteome Res. 2020 Mar 6;19(3):1147-1153
pubmed: 32037841
Nat Protoc. 2019 Jan;14(1):68-85
pubmed: 30464214
J Proteome Res. 2022 Jun 3;21(6):1418-1427
pubmed: 35522919
PLoS One. 2023 Mar 29;18(3):e0282821
pubmed: 36989217
Nat Commun. 2018 Dec 3;9(1):5128
pubmed: 30510204